{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:18:37Z","timestamp":1784855917054,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008130","name":"Pusan National University Hospital","doi-asserted-by":"publisher","award":["Biomedical Research Institute Grant (2015-05)"],"award-info":[{"award-number":["Biomedical Research Institute Grant (2015-05)"]}],"id":[{"id":"10.13039\/501100008130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10096-016-2799-1","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T04:33:15Z","timestamp":1475728395000},"page":"285-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort"],"prefix":"10.1007","volume":"36","author":[{"name":"The Korea INfectious Diseases (KIND) study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-H.","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-I.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7652-7093","authenticated-orcid":false,"given":"S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. G.","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-C.","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-I.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-H.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-D.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. B.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,6]]},"reference":[{"key":"2799_CR1","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1128\/AAC.00485-11","volume":"55","author":"S Lee","year":"2011","unstructured":"Lee S, Choe PG, Song KH, Park SW, Kim HB, Kim NJ, Kim EC, Park WB, Oh MD (2011) Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia? Antimicrob Agents Chemother 55:5122\u20135126. doi: 10.1128\/AAC.00485-11","journal-title":"Antimicrob Agents Chemother"},{"key":"2799_CR2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/clinids\/11.3.361","volume":"11","author":"I Brook","year":"1989","unstructured":"Brook I (1989) Inoculum effect. Rev Infect Dis 11:361\u2013368","journal-title":"Rev Infect Dis"},{"key":"2799_CR3","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1086\/379021","volume":"37","author":"EC Nannini","year":"2003","unstructured":"Nannini EC, Singh KV, Murray BE (2003) Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. Clin Infect Dis 37:1194\u20131198. doi: 10.1086\/379021","journal-title":"Clin Infect Dis"},{"key":"2799_CR4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1089\/mdr.2013.0229","volume":"20","author":"S Lee","year":"2014","unstructured":"Lee S, Kwon KT, Kim HI, Chang HH, Lee JM, Choe PG, Park WB, Kim NJ, Oh MD, Song DY, Kim SW (2014) Clinical implications of cefazolin inoculum effect and beta-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia. Microb Drug Resist 20:568\u2013574. doi: 10.1089\/mdr.2013.0229","journal-title":"Microb Drug Resist"},{"key":"2799_CR5","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1128\/aac.00317-09","volume":"53","author":"EC Nannini","year":"2009","unstructured":"Nannini EC, Stryjewski ME, Singh KV, Bourgogne A, Rude TH, Corey GR, Fowler VG Jr, Murray BE (2009) Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. Antimicrob Agents Chemother 53:3437\u20133441. doi: 10.1128\/aac.00317-09","journal-title":"Antimicrob Agents Chemother"},{"key":"2799_CR6","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1128\/aac.00856-13","volume":"57","author":"EC Nannini","year":"2013","unstructured":"Nannini EC, Singh KV, Arias CA, Murray BE (2013) In vivo effect of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible Staphylococcus aureus strain showing an inoculum effect against cefazolin. Antimicrob Agents Chemother 57:4276\u20134281. doi: 10.1128\/aac.00856-13","journal-title":"Antimicrob Agents Chemother"},{"key":"2799_CR7","doi-asserted-by":"publisher","first-page":"S386","DOI":"10.1093\/infdis\/128.Supplement_2.S386","volume":"128","author":"EL Quinn","year":"1973","unstructured":"Quinn EL, Pohlod D, Madhavan T, Burch K, Fisher E, Cox F (1973) Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis. J Infect Dis 128:S386\u2013S391. doi: 10.1093\/infdis\/128.Supplement_2.S386","journal-title":"J Infect Dis"},{"key":"2799_CR8","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1128\/AAC.00052-12","volume":"56","author":"DJ Livorsi","year":"2012","unstructured":"Livorsi DJ, Crispell E, Satola SW, Burd EM, Jerris R, Wang YF, Farley MM (2012) Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 56:4474\u20134477. doi: 10.1128\/AAC.00052-12","journal-title":"Antimicrob Agents Chemother"},{"key":"2799_CR9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/AAC.34.3.420","volume":"34","author":"DS Kernodle","year":"1990","unstructured":"Kernodle DS, McGraw PA, Stratton CW, Kaiser AB (1990) Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants. Antimicrob Agents Chemother 34:420\u2013425","journal-title":"Antimicrob Agents Chemother"},{"key":"2799_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.diagmicrobio.2005.09.015","volume":"54","author":"JA Shuford","year":"2006","unstructured":"Shuford JA, Piper KE, Hein M, Trampuz A, Steckelberg JM, Patel R (2006) Lack of association of Staphylococcus aureus type A beta-lactamase with cefazolin combined with antimicrobial spacer placement prosthetic joint infection treatment failure. Diagn Microbiol Infect Dis 54:189\u2013192. doi: 10.1016\/j.diagmicrobio.2005.09.015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2799_CR11","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1093\/jac\/dkt254","volume":"68","author":"S Rincon","year":"2013","unstructured":"Rincon S, Reyes J, Carvajal LP, Rojas N, Cortes F, Panesso D, Guzman M, Zurita J, Adachi JA, Murray BE, Nannini EC, Arias CA (2013) Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals. J Antimicrob Chemother 68:2773\u20132778. doi: 10.1093\/jac\/dkt254","journal-title":"J Antimicrob Chemother"},{"key":"2799_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10096-014-2241-5","volume":"34","author":"YP Chong","year":"2015","unstructured":"Chong YP, Park SJ, Kim ES, Bang KM, Kim MN, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS (2015) Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome. Eur J Clin Microbiol Infect Dis 34:349\u2013355. doi: 10.1007\/s10096-014-2241-5","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2799_CR13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.diagmicrobio.2015.07.011","volume":"83","author":"YM Wi","year":"2015","unstructured":"Wi YM, Park YK, Moon C, Ryu SY, Lee H, Ki HK, Cheong HS, Son JS, Lee JS, Kwon KT, Kim JM, Ha YE, Kang CI, Ko KS, Chung DR, Peck KR, Song JH (2015) The cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus blood isolates: their association with dysfunctional accessory gene regulator (agr). Diagn Microbiol Infect Dis 83:286\u2013291. doi: 10.1016\/j.diagmicrobio.2015.07.011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2799_CR14","unstructured":"Clinical and Laboratory Standards Institute (2008) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. CLSI document M07-A7. 7 edn. Clinical and Laboratory Standards Institute, Wayne, PA"},{"key":"2799_CR15","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/AAC.42.12.3163","volume":"42","author":"RK Voladri","year":"1998","unstructured":"Voladri RK, Kernodle DS (1998) Characterization of a chromosomal gene encoding type B beta-lactamase in phage group II isolates of Staphylococcus aureus. Antimicrob Agents Chemother 42:3163\u20133168","journal-title":"Antimicrob Agents Chemother"},{"key":"2799_CR16","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1128\/JCM.41.12.5442-5448.2003","volume":"41","author":"D Harmsen","year":"2003","unstructured":"Harmsen D, Claus H, Witte W, Rothganger J, Claus H, Turnwald D, Vogel U (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41:5442\u20135448","journal-title":"J Clin Microbiol"},{"key":"2799_CR17","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1128\/jcm.00204-07","volume":"45","author":"S Holtfreter","year":"2007","unstructured":"Holtfreter S, Grumann D, Schmudde M, Nguyen HT, Eichler P, Strommenger B, Kopron K, Kolata J, Giedrys-Kalemba S, Steinmetz I, Witte W, Broker BM (2007) Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J Clin Microbiol 45:2669\u20132680. doi: 10.1128\/jcm.00204-07","journal-title":"J Clin Microbiol"},{"key":"2799_CR18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/JCM.42.2.792-799.2004","volume":"42","author":"L Koreen","year":"2004","unstructured":"Koreen L, Ramaswamy SV, Graviss EA, Naidich S, Musser JM, Kreiswirth BN (2004) spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol 42:792\u2013799","journal-title":"J Clin Microbiol"},{"key":"2799_CR19","doi-asserted-by":"publisher","first-page":"e114127","DOI":"10.1371\/journal.pone.0114127","volume":"9","author":"ES Kim","year":"2014","unstructured":"Kim ES, Kim HB, Kim G, Kim KH, Park KH, Lee S, Choi YH, Yi J, Kim CJ, Song KH, Choe PG, Kim NJ, Lee YS, Oh MD (2014) Clinical and epidemiological factors associated with methicillin resistance in community-onset invasive Staphylococcus aureus infections: prospective multicenter cross-sectional study in Korea. PLoS One 9:e114127. doi: 10.1371\/journal.pone.0114127","journal-title":"PLoS One"},{"key":"2799_CR20","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3201\/eid1110.050141","volume":"11","author":"JM Buck","year":"2005","unstructured":"Buck JM, Como-Sabetti K, Harriman KH, Danila RN, Boxrud DJ, Glennen A, Lynfield R (2005) Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000\u20132003. Emerg Infect Dis 11:1532\u20131538. doi: 10.3201\/eid1110.050141","journal-title":"Emerg Infect Dis"},{"key":"2799_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1086\/511033","volume":"44","author":"LG Miller","year":"2007","unstructured":"Miller LG, Perdreau-Remington F, Bayer AS, Diep B, Tan N, Bharadwa K, Tsui J, Perlroth J, Shay A, Tagudar G, Ibebuogu U, Spellberg B (2007) Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 44:471\u2013482. doi: 10.1086\/511033","journal-title":"Clin Infect Dis"},{"key":"2799_CR22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1086\/322693","volume":"33","author":"TS Naimi","year":"2001","unstructured":"Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, Besser JM, O\u2019Boyle C, Danila RN, Cheek JE, Osterholm MT, Moore KA, Smith KE (2001) Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996\u20131998. Clin Infect Dis 33:990\u2013996. doi: 10.1086\/322693","journal-title":"Clin Infect Dis"},{"key":"2799_CR23","first-page":"2474","volume":"72","author":"DM Bamberger","year":"2005","unstructured":"Bamberger DM, Boyd SE (2005) Management of Staphylococcus aureus infections. Am Fam Physician 72:2474\u20132481","journal-title":"Am Fam Physician"},{"key":"2799_CR24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/AAC.33.4.407","volume":"33","author":"LD Sabath","year":"1989","unstructured":"Sabath LD (1989) Reappraisal of the antistaphylococcal activities of first-generation (narrow-spectrum) and second-generation (expanded-spectrum) cephalosporins. Antimicrob Agents Chemother 33:407\u2013411","journal-title":"Antimicrob Agents Chemother"},{"key":"2799_CR25","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1128\/aac.02800-14","volume":"58","author":"J Li","year":"2014","unstructured":"Li J, Echevarria KL, Hughes DW, Cadena JA, Bowling JE, Lewis JS 2nd (2014) Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 58:5117\u20135124. doi: 10.1128\/aac.02800-14","journal-title":"Antimicrob Agents Chemother"},{"key":"2799_CR26","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1128\/aac.04677-14","volume":"59","author":"SN Rao","year":"2015","unstructured":"Rao SN, Rhodes NJ, Lee BJ, Scheetz MH, Hanson AP, Segreti J, Crank CW, Wang SK (2015) Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 59:5232\u20135238. doi: 10.1128\/aac.04677-14","journal-title":"Antimicrob Agents Chemother"},{"key":"2799_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/cid\/ciu301","volume":"59","author":"I Youngster","year":"2014","unstructured":"Youngster I, Shenoy ES, Hooper DC, Nelson SB (2014) Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting. Clin Infect Dis 59:369\u2013375. doi: 10.1093\/cid\/ciu301","journal-title":"Clin Infect Dis"},{"key":"2799_CR28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.1977.03270330059022","volume":"237","author":"RE Bryant","year":"1977","unstructured":"Bryant RE, Alford RH (1977) Unsuccessful treatment of staphylococcal endocarditis with cefazolin. JAMA 237:569\u2013570","journal-title":"JAMA"},{"key":"2799_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1086\/589717","volume":"198","author":"KB Laupland","year":"2008","unstructured":"Laupland KB, Ross T, Gregson DB (2008) Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000\u20132006. J Infect Dis 198:336\u2013343. doi: 10.1086\/589717","journal-title":"J Infect Dis"},{"key":"2799_CR30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/00365540902801202","volume":"41","author":"M Lindqvist","year":"2009","unstructured":"Lindqvist M, Isaksson B, Samuelsson A, Nilsson LE, Hallgren A (2009) A clonal outbreak of methicillin-susceptible Staphylococcus aureus with concomitant resistance to erythromycin, clindamycin and tobramycin in a Swedish county. Scand J Infect Dis 41:324\u2013333. doi: 10.1080\/00365540902801202","journal-title":"Scand J Infect Dis"},{"key":"2799_CR31","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s10096-013-1901-1","volume":"32","author":"CF Donk van der","year":"2013","unstructured":"van der Donk CF, Schols JM, Schneiders V, Grimm KH, Stobberingh EE (2013) Antibiotic resistance, population structure and spread of Staphylococcus aureus in nursing homes in the Euregion Meuse-Rhine. Eur J Clin Microbiol Infect Dis 32:1483\u20131489. doi: 10.1007\/s10096-013-1901-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2799_CR32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/s1473-3099(12)70156-1","volume":"12","author":"MF Davis","year":"2012","unstructured":"Davis MF, Iverson SA, Baron P, Vasse A, Silbergeld EK, Lautenbach E, Morris DO (2012) Household transmission of meticillin-resistant Staphylococcus aureus and other staphylococci. Lancet Infect Dis 12:703\u2013716. doi: 10.1016\/s1473-3099(12)70156-1","journal-title":"Lancet Infect Dis"},{"key":"2799_CR33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2190\/C4U5-078N-R83L-P1MN","volume":"64","author":"M Lee","year":"2007","unstructured":"Lee M, Yoon E, Kropf NP (2007) Factors affecting burden of South Koreans providing care to disabled older family members. Int J Aging Hum Dev 64:245\u2013262","journal-title":"Int J Aging Hum Dev"},{"key":"2799_CR34","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1099\/00221287-135-4-1001","volume":"135","author":"AK East","year":"1989","unstructured":"East AK, Dyke KG (1989) Cloning and sequence determination of six Staphylococcus aureus beta-lactamases and their expression in Escherichia coli and Staphylococcus aureus. J Gen Microbiol 135:1001\u20131015. doi: 10.1099\/00221287-135-4-1001","journal-title":"J Gen Microbiol"},{"key":"2799_CR35","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1099\/00221287-134-11-2857","volume":"134","author":"MT Gillespie","year":"1988","unstructured":"Gillespie MT, Lyon BR, Skurray RA (1988) Structural and evolutionary relationships of beta-lactamase transposons from Staphylococcus aureus. J Gen Microbiol 134:2857\u20132866. doi: 10.1099\/00221287-134-11-2857","journal-title":"J Gen Microbiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2799-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2799-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2799-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T05:24:42Z","timestamp":1568438682000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2799-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2799"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2799-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,6]]}}}